The Federal Circuit addressed Teradata’s patent infringement claims against SAP in the context of the broader antitrust and interoperability dispute over enterprise database software, affirming the district court’s rulings on claim construction and damages methodology while the parallel
The Federal Circuit held that the USPTO Commissioner for Patents could constitutionally exercise the Director’s review authority over PTAB decisions during a vacancy, rejecting Arthrex’s Appointments Clause and Federal Vacancies Reform Act challenges.
The Federal Circuit affirmed a $7 million patent infringement damages verdict against Microsoft, holding that claim construction challenges must be preserved in a party’s opening brief to be raised on appeal, and reversed the denial of prejudgment interest as an abuse of discretion.
The Federal Circuit vacated a PTAB final written decision for failing to resolve conflicting expert testimony about whether a third party qualified as a joint inventor of a prior art reference, holding that the Board cannot deem all witnesses credible when their accounts are mutually contradictory.
The Federal Circuit addressed the methodology for determining FRAND royalty rates for standard-essential patents in a dispute between Apple and Ericsson over cellular connectivity patents, reviewing the district court’s FRAND determination and addressing how courts should calculate per-unit ro
The Federal Circuit reversed the PTAB’s finding of non-obviousness, holding that generalized industry skepticism about robotic surgery cannot alone overcome a motivation to combine prior art references — the skepticism must target the specific problem addressed by the claimed invention.
The Federal Circuit held that claim terms like “resilient” and “pliable” are not indefinite simply because they admit of varying degrees, reversing the district court’s indefiniteness ruling on a cardiac catheter patent.
The Federal Circuit applied the Supreme Court’s Minerva v. Hologic (2021) narrowed assignor estoppel framework to a medical device patent dispute, clarifying that assignor estoppel bars an inventor-assignee from challenging patent claims whose validity was implicitly warranted at assignment —
The Federal Circuit reversed a $137 million induced infringement verdict against Roche, holding that induced infringement requires actual knowledge that the induced acts constitute patent infringement, not merely a ‘knew or should have known’ standard.
The Federal Circuit reversed a claim construction that relied on extrinsic expert testimony to impose a specific frequency threshold on the term “input signal,” holding that extrinsic evidence cannot establish a claim scope limit that has no basis in the patent’s intrinsic record.